Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Effects of Cocarnit on Macrophages Polarization in Type 2 Diabetic Patients
Cocarnit is a metabolic complex containing disodium adenosine triphosphate trihydrate,
cocarboxylase, cyanocobalamin and nicotinamide.
Aim: To test the effects of Cocarnit on pro- and anti-inflammatory activation of
blood-derived monocytes-macrophages from Type 2 diabetic patients.
Study design: Measurements of stimulated and basal secretion of TNF-alpha and CCl-18 before
and at 2 and 4 hours after single intramuscular administration of Cocarnit at first day and
after 30 days of follow-up in 40 Type 2 diabetic patients with/without polyneuropathy.
Methods: The profile of monocyte polarization was determined in vitro in primary cell culture
of blood-derived monocytes-macrophages after pro-inflammatory stimulation by bacterial
lipopolysaccharide and after anti-inflammatory stimulation by interleukin-4, according to
tumor necrosis factor (TNF) and CCL18 chemokine secretion, respectively.
Diabetes mellitus (DM) is the most common endocrine disease, and its social significance is
associated with early disability and high mortality. Indicators of diabetes mellitus
decompensation are its chronic complications, the most common one is a diabetic
polyneuropathy. In recent years a large number of papers demonstrate the role of the chronic
inflammatory process in the development of type 2 DM. Macrophages play a key role in the
development of the inflammatory response. Macrophages are the main cells producing
pro-inflammatory cytokines, which cause a cascade of reactions leading to the development of
insulin resistance, that is the important factor of the pathogenesis of type 2 DM. There are
two main types of activation of macrophages under the influence of T-helper cells 1 and 2.
The first type is classical activation of macrophages that is a response to pro-inflammatory
stimuli, such as interferon-gamma or lipopolysaccharide. Classically activated macrophages
are well studied and characterized by the secretion of reactive oxygen species and
pro-inflammatory cytokines such as TNF-alpha, interleukins 1,6,12. The second type is
alternative activation of macrophages that is the result of the influence of
anti-inflammatory cytokines, such as interleukins 4,10,13 or anti-inflammatory mediators, for
example, glucocorticoids. The result of alternative activation of macrophages is the
expression of anti-inflammatory cytokines such as antagonist receptor interleukin 1,
interleukin 10, CCL18, haptoglobin receptor CD163, scavenger receptor type1.
Cocarnit is a metabolic complex containing disodium adenosine triphosphate trihydrate 10mg,
cocarboxylase 50mg, cyanocobalamin 500mg and nicotinamide 20mg.
The aim of the present study is to test the effects of Cocarnit on pro- and anti-inflammatory
activation of blood-derived monocytes-macrophages from Type 2 diabetic patients.
The profile of monocyte polarization was determined in vitro in primary cell culture of
blood-derived monocytes-macrophages after pro-inflammatory stimulation by bacterial
lipopolysaccharide and after anti-inflammatory stimulation by interleukin-4, according to
tumor necrosis factor (TNF) and CCL18 chemokine secretion, respectively.
Study design: Open label study included 40 Type 2 diabetic patients divided into two groups:
1. Newly-diagnosed type-2 DM - 20 participants;
2. Type-2 DM with polyneuropathy - 20 participants.
The following measurements are held:
1. stimulated and basal secretion of TNF-alpha before and at 2 and 4 hours after single
intramuscular administration of Cocarnit at first day and 30 days of follow-up.
2. stimulated and basal secretion of CCl-18 before and at 2 and 4 hours after single
intramuscular administration of Cocarnit at first day and after 30 days of follow-up.
The research database is compiled upon completion of the study and then a statistical
analysis of the results is carried out.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |